Home » Topics » Regulatory

Regulatory
RSS

Columbia Laboratories issued U.S. patent for drug delivery technology

Sep. 23, 1997

Cardizem Monovial approved for U.S. marketing

Sep. 23, 1997

Clinical trials begin with topical impotence treatment

Sep. 23, 1997

Octreotide acetate clinical study commences for new indication

Sep. 23, 1997

Celgene's thalidomide approvable for ENL

Sep. 23, 1997

FDA panel recommends approval of Paxene

Sep. 22, 1997

First approvals for Lovenox/Clexane in unstable angina/MI

Sep. 22, 1997

Famvir approved by FDA for new indication

Sep. 22, 1997

Phase I results reported for MiKasome

Sep. 22, 1997

Andrx's extended-release diltiazem receives tentative approval

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...